HSK16149

DRUG2 trials

Sponsors

Haisco Pharmaceutical Group Co., Ltd.

Conditions

Diabetic NeuropathiesDiabetic Neuropathy PeripheralRenal Impairment

Phase 1

A Study Evaluating Drug-Drug Interaction (DDI) Between HSK16149 Capsules and Metformin Hydrochloride Tablets

Haisco Pharmaceutical Group Co., Ltd.Diabetic Neuropathies, Diabetic Neuropathy Peripheral

Start: 2021-04-01End: 2021-08-15Target: 22Updated: 2021-04-12

A Study to Evaluate the Pharmacokinetics of HSK16149 in Subjects With Renal Impairment

CompletedNCT05916573

Haisco Pharmaceutical Group Co., Ltd.Renal Impairment

Start: 2022-12-12End: 2023-04-26Updated: 2023-06-23